ChemicalBook > CAS DataBase List > Naptumomab estafenatox

Naptumomab estafenatox

Product Name
Naptumomab estafenatox
CAS No.
676258-98-3
Chemical Name
Naptumomab estafenatox
Synonyms
Naptumomab estafenatox;Research Grade Naptumomab(DHG62601)
CBNumber
CB82498823
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Naptumomab estafenatox Chemical Properties,Usage,Production

Uses

Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.

Naptumomab estafenatox Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Naptumomab estafenatox Suppliers

China 11 Global 11
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9248
Advantage
55
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
89689
Advantage
60
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9866
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
7062
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11972
Advantage
58
Changsha Fuzhen Biotechnology Co.，LTD
Tel
18229892877 13823398779
Email
3062105966@qq.com
Country
China
ProdList
5373
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6738
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58

676258-98-3, Naptumomab estafenatoxRelated Search:

Prasinezumab Tovetumab Relatlimab Sonelokimab Durvalumab Bococizumab Tusamitamab Encelimab Tildrakizumab Girentuximab

  • Naptumomab estafenatox
  • Research Grade Naptumomab(DHG62601)
  • 676258-98-3